Oscar Health
(NYSE) OSCR
Oscar Health Financials at a Glance
Market Cap
$9.70B
Revenue (TTM)
$13.30B
Net Income (TTM)
-$39.43M
EPS (TTM)
-$0.61
P/E Ratio
-52.79
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$32.06
Volume
7,251,286
Open
$32.24
Price
$32.06
Volume
7,251,286
Open
$32.24
Previous Close
$32.18
Daily Range
$31.68 - $33.10
52-Week Range
$10.69 - $33.10
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$32.06
Volume
7,251,286
Open
$32.24
Previous Close
$32.18
Daily Range
$31.68 - $33.10
52-Week Range
$10.69 - $33.10
Estimated Earnings Date
Aug 5, 2026
OSCR News
OSCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oscar Health
Industry
Insurance
Sector
FinancialsEmployees
2,305
CEO
Mark T. Bertolini, MBA
Website
www.hioscar.comHeadquarters
New York City, NY 10013, US
OSCR Financials
Key Financial Metrics (TTM)
Gross Margin
17.39%
Operating Margin
0.08%
Net Income Margin
-0.30%
Return on Equity
-3.27%
Return on Capital
-28.16%
Return on Assets
-0.42%
Earnings Yield
-1.89%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$9.70B
Shares Outstanding
301.49M
Volume
7.25M
Avg. Volume
7.59M
Financials (TTM)
Gross Profit
$2.31B
Operating Income
$10.61M
EBITDA
$19.23M
Operating Cash Flow
$2.84B
Capital Expenditure
-$36.14M
Free Cash Flow
$2.80B
Cash & ST Invst.
$6.80B
Total Debt
$430.88M
Oscar Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.65B
+52.6%
Gross Profit
$1.42B
+80.2%
Gross Margin
30.50%
N/A
Market Cap
$9.70B
N/A
Market Cap/Employee
$4.04M
N/A
Employees
2,400
N/A
Net Income
$679.00M
+146.7%
EBITDA
$711.15M
+136.3%
Quarterly Fundamentals
Total Cash
$6.80B
+127.6%
Total Debt
$430.88M
+43.7%
Accounts Receivable
$587.02M
-23.1%
Inventory
$0.00
N/A
Long Term Debt
$430.88M
+43.7%
Short Term Debt
$0.00
N/A
Return on Assets
-0.42%
N/A
Return on Invested Capital
0.49%
N/A
Free Cash Flow
$2.61B
+200.2%
Operating Cash Flow
$2.62B
+198.1%